Digital Health Coaching for Multiple Myeloma
Trial Summary
What is the purpose of this trial?
This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on digital health coaching rather than medication changes.
What data supports the effectiveness of the Digital Health Coaching Program for Multiple Myeloma?
Research shows that digital health strategies, like educational programs and wearable devices, can improve treatment adherence and quality of life for multiple myeloma patients. These tools help patients better understand their condition and manage their treatment, leading to better health outcomes.12345
Is digital health coaching using devices like Fitbit safe for humans?
How does digital health coaching differ from other treatments for multiple myeloma?
Digital health coaching for multiple myeloma is unique because it uses technology to provide personalized support and guidance, potentially improving patient outcomes by promoting healthy lifestyle changes and symptom management. Unlike traditional treatments, it focuses on integrating digital tools like mobile apps and wearable devices to enhance patient engagement and self-management.711121314
Research Team
Rahul Banerjee, MD
Principal Investigator
University of Washington
Eligibility Criteria
Adults over 18 with relapsed or refractory multiple myeloma, who have undergone at least one prior treatment including a proteasome inhibitor or immunomodulatory drug. Not for those with less than 6 months to live, without smartphone access, insufficient English proficiency, or on conflicting R/R MM studies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Digital Health Coaching Program
Participants are enrolled in a 3-month digital health coaching program, receiving weekly phone calls and learning materials via text or email. They will also wear a Fitbit device to capture physical activity data.
Follow-up
Participants are monitored for changes in treatment experience, quality of life, and other outcomes after the digital health coaching program.
Treatment Details
Interventions
- Digital Health Coaching Program
- Fitbit
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pack Health
Lead Sponsor
University of Washington
Collaborator
GlaxoSmithKline
Industry Sponsor
Dame Emma Walmsley
GlaxoSmithKline
Chief Executive Officer since 2017
MA in Classics and Modern Languages from Oxford University
Dr. Hal Barron
GlaxoSmithKline
Chief Medical Officer since 2018
MD from Harvard Medical School